The Stanley Medical Research Institute

The Stanley Medical Research Institute

The Stanley Medical Research Institute

Overview
Date Founded

2001

Headquarters

10605 CONCORD ST STE 206 KENSINGTON MD 20895-2526

Charitable Causes

Medical Research

Employees (Worldwide)

13

Industries

Other Business & Consulting Services
Medical Support Services

Company Description

The Stanley Medical Research Institute supports research for treatment of schizophrenia and bipolar disorder. It expertise in treatment Trials of biological interventions and brain research disorder issues. The company was founded in 1989 and is headquartered in Kensington, MD.

Contact Data
Trying to get in touch with decision makers at The Stanley Medical Research Institute? Subscribe today to access their professional contact information.
Executives & Employees

Associate Director-Research

Associate Director of Research

Associate Director-Administration

Associate Director-Laboratory Research

Associate Director-Treatment Trials

Manager-Information Systems

Property Manager

Board of Directors

Associate Director-Laboratory Research at The Stanley Medical Research Institute

Paths to The Stanley Medical Research Institute
Potential Connections via
Relationship Science
You
The Stanley Medical Research Institute
Key Stats and Financials As of 2016
Market Capitalization
Total Enterprise Value
Earnings Per Share
Revenue
$13M
Investments
Details Hidden

Omeros Corp. operates as a biopharmaceutical company specializes in discovery, development, and commercializes of both small-molecule and protein therapeutics for large -market as well as orphan indications targeting inflammation, coagulopathies and disorders of the central nervous system. The company was founded by Gregory A. Demopulos and Pamela Pierce Palmer on June 16, 1994 and is headquartered in Seattle, WA.

Details Hidden

Saegis Pharmaceuticals, Inc. developed drug therapeutics. Its phase II SGS742 clinical drug treated diseases such as mild cognitive impairment and attention deficit hyperactivity disorder. Its second SGS742 clinical trial provided coronary artery bypass surgery. The company was founded in 1999 and was headquartered in Half Moon Bay, CA.

Details Hidden

Argolyn Bioscience, Inc. discovers and develops therapeutic products. It uses amino acid analog substitution technology to enable discovery of novel drug candidates. The firm's products pipeline include library construction, lead identification, and preclinical & clinical development. The company was founded by Thomas A. Dix in May 2002 and is headquartered in Durham, NC.